Agenix submits manufacturing patent application for hepatitis B drug
The patent application includes the manufacturing process of a compound that uses thesame active ingredient, Tenofovir, used in a drug marketed by Gilead Sciences under the trade name
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.